71 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
MRK Merck & Company, Inc. $70.42 $187.28B N/A
Article Searches
Merck's Pediatric Filings for Dificid Get FDA's Priority Review http://www.zacks.com/stock/news/547611/mercks-pediatric-filings-for-dificid-get-fdas-priority-review?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-547611 Oct 03, 2019 - The FDA accepts and grants a priority review to Merck's (MRK) two filings for pediatric approvals of antibacterial medicine Dificid for Clostridium infections. The verdict will be out on Jan 24, 2020.
Novo Nordisk Focuses on Pipeline Development Amid Competition http://www.zacks.com/stock/news/552953/novo-nordisk-focuses-on-pipeline-development-amid-competition?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-552953 Oct 07, 2019 - Novo Nordisk (NVO) has a strong presence in the Diabetes care market and focuses on the development of its pipeline amid competition.
Top Ranked Growth Stocks to Buy for October 10th http://www.zacks.com/commentary/557775/top-ranked-growth-stocks-to-buy-for-october-10th?cid=CS-ZC-FT-zacks_#1_rank_additions-557775 Oct 10, 2019 - Top Ranked Growth Stocks to Buy for October 10th
Why Merck (MRK) is Poised to Beat Earnings Estimates Again http://www.zacks.com/stock/news/563650/why-merck-mrk-is-poised-to-beat-earnings-estimates-again?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-563650 Oct 14, 2019 - Merck (MRK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Dividend-Paying Pharma Stocks to Buy Now https://www.fool.com/investing/2019/10/15/3-dividend-paying-pharma-stocks-to-buy-now.aspx?source=iedfolrf0000001 Oct 15, 2019 - These aren't the highest payouts in the industry, but they have the best chance to steadily climb.
J&J (JNJ) Beats on Q3 Earnings as Sales Rise, Ups 2019 View http://www.zacks.com/stock/news/565810/jj-jnj-beats-on-q3-earnings-as-sales-rise-ups-2019-view?cid=CS-ZC-FT-analyst_blog|earnings_article-565810 Oct 15, 2019 - J&J (JNJ) comes up with encouraging third-quarter 2019 results.
Are You Looking for a High-Growth Dividend Stock? Merck (MRK) Could Be a Great Choice http://www.zacks.com/stock/news/571032/are-you-looking-for-a-high-growth-dividend-stock-merck-mrk-could-be-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-571032 Oct 18, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes? Let's find out.
3 Cancer Treatment Stocks to Buy Right Now https://www.fool.com/investing/2019/10/23/3-cancer-treatment-stocks-to-buy-right-now.aspx?source=iedfolrf0000001 Oct 23, 2019 - These stocks have track records of success and plenty of growth ahead.
Why Earnings Season Could Be Great for Merck (MRK) http://www.zacks.com/stock/news/588664/why-earnings-season-could-be-great-for-merck-mrk?cid=CS-ZC-FT-tale_of_the_tape|earnings_surprise-588664 Oct 28, 2019 - Merck (MRK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Drug/Biotech Stock Q3 Earnings Due on Oct 29: MRK, PFE & More http://www.zacks.com/stock/news/588895/drug-biotech-stock-q3-earnings-due-on-oct-29-mrk-pfe-more?cid=CS-ZC-FT-analyst_blog:_earnings_preview_-_esp|earnings_preview_-_esp-588895 Oct 28, 2019 - Four drug/biotech stocks are scheduled to release third-quarter results on Oct 29. Let's see how these companies are placed before their earnings call.

Pages: 12345678

<<<Page 6>